Biohack the Planet | Jo Zayner, PhD | Substack

Recently, news broke that Intellia Therapeutics, a pharmaceutical company that focuses on CRISPR gene editing received FDA clearance to use their drug dubbed NTLA-2002 in broader clinical trials. Honestly, that's not really very interesting. This isn't the first gene editing drug…

Mar 6

New Top Community

Tyrell Corporation Human Resources

Feb 28

Change your genes NOW

Jan 16

Jan 6

The death of the synthetic biology company and the rise of consumer biotech. I’ma be honest, I’ve been pushing on the consumer biotech thing before…

Jan 2

Gene therapies have revolutionized medicine. They are a functional cure for diseases by replacing mutated copies of genes in the patient’s cells with a…

Dec 28, 2022

and less body mod shaming

Dec 24, 2022

We are trying to meet the demands of the biological world we live in with everything but biology. I truly believe that as genetic engineering becomes…

Dec 20, 2022

Biohack the Planet

About Archive Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts